Exploration of the gut microbiome in Thai patients with major depressive disorder uncovered a specific bacterial profile with depletion of theRuminococcusgenus as a putative biomarker

Abstract

AbstractMaes et al. (2008) published the first paper demonstrating that major depressive disorder (MDD) is accompanied by abnormalities in the microbiota-gut-brain axis, as evidenced by elevated serum IgM/IgA to lipopolysaccharides (LPS) of Gram-negative bacteria, such asMorganella morganiiandKlebsiella Pneumoniae. The latter aberrations, which point to increased gut permeability (leaky gut), are linked to activated neuro-immune and oxidative pathways in MDD. To delineate the profile and composition of the gut microbiome in Thai patients with MDD, we examined fecal samples of 32 MDD patients and 37 controls using 16S rDNA sequencing and analyzed α-(Chao and Shannon indices) and β-diversity (Bray-Curtis dissimilarity) and conducted Linear discriminant analysis (LDA) Effect Size (LEfSe) analysis. Neither α-nor β-diversity differed significantly between MDD and controls.Rhodospirillaceae, Hungatella, Clostridium bolteae, Hungatella hathewayi, andClostridium propionicumwere significantly enriched in MDD, while Gracillibacteraceae family,Lutispora, and Ruminococcus genus, Ruminococcus callidus, Desulfovibrio piger, Coprococcus comes, andGemmiger, were enriched in controls. Contradictory results have been reported for all these taxa, with the exception ofRuminococcuswhich is depleted in 6 different MDD studies (one study showed increased abundance), many medical disorders that show comorbidities with MDD, and animal MDD models. Our results may suggest a specific profile of compositional gut dysbiosis in Thai MDD patients with increases in some pathobionts and depletion of some beneficial microbiota. The results suggest that depletion ofRuminococcusmay be a more universal biomarker of MDD that maybe contributes to increased enteral LPS load, LPS translocation, and gut-brain axis abnormalities.